Morgan Stanley (MS) Stock Forecast
MS analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.80 / 5 from 25 analysts
- Price target
- $213.27 average of analyst targets
- Upside to target
- +18.1% from the latest close
- Next earnings
- —
- 52-week range
- $154.37 – $228.55
MS analyst ratings
25 analystsNumber of analysts at each rating.
MS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
MS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.92 | $2.60 | $3.19 | $2.80 | +4.1% | 16 |
| Next quarter (Mar '27) | $3.62 | $3.28 | $4.00 | $3.43 | +5.6% | 10 |
| Current fiscal year (2026) | $12.81 | $12.39 | $13.15 | $10.21 | +25.5% | 21 |
| Next fiscal year (2027) | $13.66 | $11.80 | $14.56 | $12.81 | +6.6% | 22 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
MS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $20.11B | $19.78B | $21.48B | +10.3% | 14 |
| Next quarter (Mar '27) | $22.18B | $21.30B | $23.36B | +7.8% | 7 |
| Current fiscal year (2026) | $82.18B | $79.25B | $83.40B | +16.3% | 18 |
| Next fiscal year (2027) | $86.68B | $80.79B | $89.32B | +5.5% | 18 |
MS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
MS revenue: reported and forecast
MS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.95 | $3.16 | $3.16 | $3.09 | $2.92 | −1.0% | 2 up · 5 down |
| Next quarter (Mar '27) | $3.67 | $3.67 | $3.71 | $3.61 | $3.62 | −1.3% | 1 up · 5 down |
| Current fiscal year (2026) | $12.96 | $12.98 | $12.98 | $12.72 | $12.81 | −1.1% | 1 up · 16 down |
| Next fiscal year (2027) | $13.52 | $13.65 | $13.68 | $13.60 | $13.66 | +1.0% | 4 up · 13 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
MS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; MS beat in 11 of 12.
What analysts expect from MS
25 analysts cover Morgan Stanley; their consensus rating is buy (3.80 on a 1–5 scale, where 5 is a strong buy). The average price target is $213.27, 18.1% above the latest close of $180.57. Analysts expect earnings of $12.81 per share for 2026, +25.5% from a year earlier. For 2027 the average estimate is $13.66 per share on revenue of $86.7 billion. Morgan Stanley beat the EPS estimate in 11 of the last 12 quarters.
Related: MS income statement, MS key metrics, MS chart. See the MS stock overview for the latest quote and news.
MS forecast FAQ
What is Morgan Stanley's price target?
The average analyst price target for Morgan Stanley is $213.27, 18.1% above the latest close of $180.57.
Is Morgan Stanley a buy, hold or sell?
Of 25 analysts covering Morgan Stanley, 9 rate it a strong buy, 2 a buy, 14 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Morgan Stanley's EPS forecast?
Analysts forecast $12.81 per share for 2026 (range $12.39 to $13.15); for 2027 the estimate is $13.66.
What is Morgan Stanley's revenue forecast?
The average revenue estimate for 2026 is $82.2 billion, growth of 16.3%; for 2027 it is $86.7 billion.
Does Morgan Stanley usually beat earnings estimates?
Morgan Stanley reported EPS at or above the analyst estimate in 11 of the last 12 quarters.